The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
The Regulatory Role of MicroRNAs in Breast Cancer
Open accessAbstract
MicroRNAs (miRNAs) are small non-coding RNA molecules which function as critical post-transcriptional gene regulators of various biological functions. Generally, miRNAs negatively regulate gene expression by binding to their selective messenger RNAs (mRNAs), thereby leading to either mRNA degradation or translational repression, depending on the degree of complementarity with target mRNA sequences. Aberrant expression of these miRNAs has been linked etiologically with various human diseases including breast cancer. Different cellular pathways of breast cancer development such as cell proliferation, apoptotic response, metastasis, cancer recurrence and chemoresistance are regulated by either the oncogenic miRNA (oncomiR) or tumor suppressor miRNA (tsmiR). In this review, we highlight the current state of research into miRNA involved in breast cancer, with particular attention to articles published between the years 2000 to 2019, using detailed searches of the databases PubMed, Google Scholar, and Scopus. The post-transcriptional gene regulatory roles of various dysregulated miRNAs in breast cancer and their potential as therapeutic targets are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin
Zhang, J., Liu, D., Feng, Z., Mao, J., Zhang, C., Lü, Y., Li, J., Zhang, Q., Li, Q., & Li, L. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.018 · Cited by 98
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
miRBase: from microRNA sequences to function
Kozomara, A., Birgaoanu, M., & Griffiths-Jones, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1141 · Cited by 4,843
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
The Drosha-DGCR8 complex in primary microRNA processing
Han, J., Lee, Y., Yeom, K.-H., Kim, Y.-K., Jin, H., & Kim, V. N. (2004) · Genes & Development · doi:10.1101/gad.1262504 · Cited by 2,220
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature03868 · Cited by 2,100
Risk Factors and Preventions of Breast Cancer
Sun, Y.-S., Zhao, Z., Yang, Z.-N., Xu, F., Lu, H.-J., Zhu, Z.-Y., Shi, W., Jiang, J., Yao, P.-P., & Zhu, H.-P. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21635 · Cited by 2,003
The CRISPR tool kit for genome editing and beyond
Adli, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04252-2 · Cited by 1,545
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
RNA polymerase III transcribes human microRNAs
Borchert, G. M., Lanier, W., & Davidson, B. L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1167 · Cited by 1,393
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,190
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair
Johnson, K. E., & Wilgus, T. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0517 · Cited by 1,100
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Dai, X., Cheng, H., Bai, Z., & Li, J. (2017) · Journal of Cancer · doi:10.7150/jca.18457 · Cited by 1,100
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Heterogeneity in breast cancer
Polyak, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60534 · Cited by 1,006
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
Jeanes, A., Gottardi, C. J., & Yap, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.343 · Cited by 772
Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 767
MicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Jafri, M. A., Ansari, S. A., Alqahtani, M. H., & Shay, J. W. (2016) · Genome Medicine · doi:10.1186/s13073-016-0324-x · Cited by 716
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Mammalian cell transfection: the present and the future
Kim, T. K., & Eberwine, J. H. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3821-6 · Cited by 678
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
Zhou, S.-S., Jin, J.-P., Wang, J.-Q., Zhang, Z.-G., Freedman, J. H., Zheng, Y., & Cai, L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.30 · Cited by 675
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
Reddy, K. B. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0185-1 · Cited by 613
MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease
Bhaskaran, M., & Mohan, M. (2014) · Veterinary Pathology · doi:10.1177/0300985813502820 · Cited by 605
Tumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance
Makki, J. (2015) · Clinical Medicine Insights: Pathology · doi:10.4137/cpath.s31563 · Cited by 583
Liu, C.-Y., Lin, H.-H., Tang, M.-J., & Wang, Y.-K. (2015) · Oncotarget · doi:10.18632/oncotarget.3862 · Cited by 533
microRNA Therapeutics in Cancer — An Emerging Concept
Shah, M. Y., Ferrajoli, A., Sood, A. K., Lopez-Berestein, G., & Calin, G. A. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.017 · Cited by 453
Role of microRNAs in translation regulation and cancer
Oliveto, S., Mancino, M., Manfrini, N., & Biffo, S. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.45 · Cited by 431
E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
Tian, X., Liu, Z., Niu, B., Zhang, J., Tan, T. K., Lee, S. R., Zhao, Y., Harris, D. C. H., & Zheng, G. (2011) · BioMed Research International · doi:10.1155/2011/567305 · Cited by 424
ATP-dependent human RISC assembly pathways
Yoda, M., Kawamata, T., Paroo, Z., Ye, X., Iwasaki, S., Liu, Q., & Tomari, Y. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1733 · Cited by 380
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
Structure and activity of putative intronic miRNA promoters
Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y., & Davidson, B. L. (2010) · RNA · doi:10.1261/rna.1731910 · Cited by 367
Pakravan, K., Babashah, S., Sadeghizadeh, M., Mowla, S. J., Mossahebi-Mohammadi, M., Ataei, F., Dana, N., & Javan, M. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0335-7 · Cited by 346
MicroRNAs in apoptosis, autophagy and necroptosis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.3523 · Cited by 342
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Dysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 315
Genomic organization of microRNAs
Olena, A. F., & Patton, J. G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21993 · Cited by 275
Role of hypoxia-inducible factors in breast cancer metastasis
Gilkes, D. M., & Semenza, G. L. (2013) · Future Oncology · doi:10.2217/fon.13.92 · Cited by 274
MicroRNA Therapeutics: the Next Magic Bullet?
Simonson, B., & Das, S. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150324123208 · Cited by 263
Intracellular and Extracellular MicroRNAs in Breast Cancer
Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J., & O'Driscoll, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150730 · Cited by 225
Biogenesis of mammalian microRNAs by a non-canonical processing pathway
Havens, M. A., Reich, A. A., Duelli, D. M., & Hastings, M. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks026 · Cited by 222
New dimension of glucocorticoids in cancer treatment
Lin, K.-T., & Wang, L.-H. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.019 · Cited by 204
MicroRNAs and cancer: Key paradigms in molecular therapy (Review)
Tan, W., Liu, B., Qu, S., Liang, G., Luo, W., & Gong, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7638 · Cited by 200
Regulation of multidrug resistance by microRNAs in anti-cancer therapy
An, X., Sarmiento, C., Tan, T., & Zhu, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.002 · Cited by 194
van Schooneveld, E., Wouters, M. C., Van der Auwera, I., Peeters, D. J., Wildiers, H., Van Dam, P. A., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3127 · Cited by 191
Pathophysiological Basis for the Formation of the Tumor Microenvironment
Horsman, M. R., & Vaupel, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00066 · Cited by 189
MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
Wang, W. T., & Luo, Y. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400184 · Cited by 186
Camps, C., Saini, H. K., Mole, D. R., Choudhry, H., Reczko, M., Guerra‐Assunção, J. A., Tian, Y., Buffa, F. M., Harris, A. L., Hatzigeorgiou, A. G., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-28 · Cited by 182
Mallanna, S. K., & Rizzino, A. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.05.014 · Cited by 180
Transcriptional regulation of mammalian miRNA genes
Schanen, B. C., & Li, X. (2011) · Genomics · doi:10.1016/j.ygeno.2010.10.005 · Cited by 173
Pathways to Breast Cancer Recurrence
Ahmad, A. (2013) · ISRN Oncology · doi:10.1155/2013/290568 · Cited by 172
MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Lu, Y., Qin, T., Li, J., Wang, L., Zhang, Q., Jiang, Z., & Mao, J. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.30 · Cited by 170
Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit
Costales, M. G., Haga, C. L., Velagapudi, S. P., Childs-Disney, J. L., Phinney, D. G., & Disney, M. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11273 · Cited by 164
Long, H., Wang, X., Chen, Y., Wang, L., Zhao, M., & Lu, Q. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.016 · Cited by 162
Mechanisms of telomere loss and their consequences for chromosome instability
Muraki, K., Nyhan, K., Han, L., & Murnane, J. P. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00135 · Cited by 159
Kurozumi, S., Yamaguchi, Y., Kurosumi, M., Ohira, M., Matsumoto, H., & Horiguchi, J. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2016.89 · Cited by 159
Hong, B. S., Ryu, H. S., Kim, N., Kim, J., Lee, E.-S., Moon, H., Kim, K. H., Jin, M., Kwon, N. H., Kim, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0891 · Cited by 158
Miao, Y., Zheng, W., Li, N., Su, Z., Zhao, L., Zhou, H., & Li, J. (2017) · Scientific Reports · doi:10.1038/srep41942 · Cited by 150
Noncanonical functions of micro RNA pathway enzymes – Drosha, DGCR 8, Dicer and Ago proteins
Pong, S. K., & Gullerová, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13196 · Cited by 148
MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
Lin, Y., Liu, A. Y., Fan, C., Zheng, H., Li, Y., Zhang, C., Wu, S., Yu, D., Huang, Z., Liu, F., et al. (2015) · Scientific Reports · doi:10.1038/srep09995 · Cited by 141
MiRNA-based therapeutic intervention of cancer
Naidu, S., Magee, P., & Garofalo, M. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0162-0 · Cited by 140
Zhang, G., Zhang, W., Li, B., Stringer-Reasor, E. M., Chu, C., Sun, L., Bae, S., Chen, D., Wei, S., Jiao, K., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0858-x · Cited by 139
Interplay between miRNAs and host genes and their role in cancer
Liu, B., Shyr, Y., Cai, J., & Liu, Q. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz002 · Cited by 137
miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
Dinami, R., Ercolani, C., Petti, E., Piazza, S., Ciani, Y., Sestito, R., Sacconi, A., Biagioni, F., le Sage, C., Agami, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2038 · Cited by 130
Breunig, C., Pahl, J. H. W., Kueblbeck, M., Miller, M., Antonelli, D., Erdem, N., Wirth, C., Will, R. D., Bott, A., Cerwenka, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.364 · Cited by 130
Li, Y., Cai, B., Shen, L., Dong, Y., Lu, Q., Sun, S., Liu, S., Ma, S., Ma, P. X., & Chen, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.032 · Cited by 129
Control of telomerase action at human telomeres
Hockemeyer, D. F., & Collins, K. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3083 · Cited by 124
On Measuring miRNAs after Transient Transfection of Mimics or Antisense Inhibitors
Thomson, D. W., Bracken, C. P., Szubert, J. M., & Goodall, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055214 · Cited by 122
miRIAD—integrating microRNA inter- and intragenic data
Hinske, L. C., França, G. S., Torres, H. A. M., Ohara, D. T., Lopes‐Ramos, C. M., Heyn, J., Reis, L. F. L., Lucila Ohno-machado, A., Kreth, S., & Galante, P. A. F. (2014) · Database · doi:10.1093/database/bau099 · Cited by 119
Zhou, J., Tan, X., Tan, Y., Li, Q., Ma, J., & Wang, G. (2018) · Journal of Cancer · doi:10.7150/jca.25376 · Cited by 118
Balancing the decision of cell proliferation and cell fate
Hallstrom, T. C., & Nevins, J. R. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7609 · Cited by 112
Shukla, K., Sharma, A. K., Ward, A., Will, R. D., Hielscher, T., Balwierz, A., Breunig, C., Münstermann, E., König, R., Keklikoglou, I., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.01.008 · Cited by 111
Jiang, X., Yu, X., Liu, T., Zhu, H., Shi, X., Bilegsaikhan, E., Guo, H., Song, G., Weng, S., Huang, X., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.097 · Cited by 110
Hannafon, B. N., Cai, A., Calloway, C. L., Xu, Y., Zhang, R., Fung, K., & Ding, W. (2019) · BMC Cancer · doi:10.1186/s12885-019-5839-2 · Cited by 110
MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1
Zhan, M., Yu, X., Tang, J., Zhou, C.-X., Wang, C.-L., Yin, Q., Gong, X.-F., He, M., He, J., Chen, G., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.440 · Cited by 106
Chen, L.-L., Zhang, Z., Yi, Z.-B., & Li, J.-J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.150 · Cited by 104
Nagpal, N., Ahmad, H. M., Chameettachal, S., Sundar, D., Ghosh, S., & Kulshreshtha, R. (2015) · Scientific Reports · doi:10.1038/srep09650 · Cited by 102
Mohammadi‐Yeganeh, S., Paryan, M., Arefian, E., Vasei, M., Ghanbarian, H., Mahdian, R., Karimipoor, M., & Soleimani, M. (2016) · Tumor Biology · doi:10.1007/s13277-015-4513-9 · Cited by 101
MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs
Bhardwaj, A., Singh, S., & Singh, A. (2010) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.10.27 · Cited by 97
MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer
Luo, Q., Li, X., Gao, Y., Long, Y., Chen, L., Huang, Y., & Fang, L. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-95 · Cited by 95
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Pavlopoulou, A., Oktay, Y., Vougas, K. N., Louka, M. A., Vorgias, C. E., & Georgakilas, A. G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.018 · Cited by 93
Target RNAs Strike Back on MicroRNAs
Fuchs Wightman, F., Giono, L. E., Fededa, J. P., & de la Mata, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00435 · Cited by 92
Hua, K., Jin, J., Zhao, J., Song, J., Song, H., LI, D., Maskey, N., Zhao, B., Wu, C., Xu, H., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3405 · Cited by 90
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
Roscigno, G., Puoti, I., Giordano, I., Donnarumma, E., Russo, V. M., Affinito, A., Adamo, A., Quintavalle, C., Todaro, M., Vivanco, M. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14470 · Cited by 87
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
McAnena, P. F., Tanrıverdi, K., Curran, C. E., Gilligan, K., Freedman, J. E., Brown, J. A. L., & Kerin, M. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5636-y · Cited by 86
Chu, J., Zhu, Y., Liu, Y., Sun, L., Lv, X., Wu, Y., Hu, P., Su, F., Gong, C., Song, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5128 · Cited by 85
Jin, T., Kim, H. S., Choi, S. K., Hwang, E. H., Woo, J., Ryu, H. S., Kim, K., Moon, A., & Moon, W. K. (2017) · Oncotarget · doi:10.18632/oncotarget.15680 · Cited by 82
miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α
WU, Z., Cai, X., Huang, C., XU, J., & Liu, A. (2015) · Oncology Reports · doi:10.3892/or.2015.4529 · Cited by 80
Tormo, E., Adam‐Artigues, A., Ballester, S., Pineda, B., Zazo, S., Gónzález-Alonso, P., Albanell, J., Rovira, A., Rojo, F., Lluch, A. M., et al. (2017) · Scientific Reports · doi:10.1038/srep41309 · Cited by 77
Signatures of breast cancer metastasis at a glance
Karagiannis, G. S., Goswami, S., Jones, J. G., Oktay, M. H., & Condeelis, J. S. (2016) · Journal of Cell Science · doi:10.1242/jcs.183129 · Cited by 76
CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation
Wang, H., & Sun, W. Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.033 · Cited by 76
MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1
Xie, F., Hosany, S., Zhong, S., Jiang, Y., Zhang, F., Lin, L., Wang, X., Gao, S., & Hu, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185565 · Cited by 75
Wang, X., Qiu, W., Zhang, G., Xu, S., Gao, Q., & Yang, Z. (2015) · PubMed · Cited by 73
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
Kader, T., Hill, P., Rakha, E. A., Campbell, I., & Gorringe, K. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0967-1 · Cited by 72
Nahta, R., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., Andrade-Vieira, R., Bay, S., Brown, D. G., Calaf, G. M., Castellino, R. C., Cohen-Solal, K., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv028 · Cited by 69
microRNAs in Neurodegeneration: Current Findings and Potential Impacts
Sharma, S., & Lu, H. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000420 · Cited by 69
Shen, F., Cai, W.-S., Feng, Z., Li, J., Chen, J., Cao, J., & Xu, B. (2014) · Tumor Biology · doi:10.1007/s13277-014-2794-z · Cited by 67
Chen, P., Xu, W., Luo, Y., Zhang, Y., He, Y., Yang, S., & Yuan, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s118366 · Cited by 65
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Wang, H., Liu, S., Li, J., Chu, F., Zhou, Y., He, Z., Guo, M., Chen, C., & Xu, L. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0596-x · Cited by 64
Manson, Q. F., Schrijver, W. A. M. E., ter Hoeve, N. D., Moelans, C. B., & van Diest, P. J. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9950-6 · Cited by 63
Li, P., Guo, Y., Bledsoe, G., Yang, Z., Chao, L., & Chao, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.004 · Cited by 62
Antiangiogenic mechanisms and factors in breast cancer treatment
Vishwanatha, J. K., & Castañeda-Gill, J. (2016) · Journal of Carcinogenesis · doi:10.4103/1477-3163.176223 · Cited by 59
The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation
Trivanović, D. I., Krstić, J., Djordjević, I. O., Mojsilović, S. B., Santibanez, J. F., Bugarski, D. S., & Jauković, A. (2016) · Mediators of Inflammation · doi:10.1155/2016/7314016 · Cited by 56
miR-455 inhibits breast cancer cell proliferation through targeting CDK14
Wang, B., Zou, A., Ma, L., Chen, X., Wang, L., Zeng, X., & Tan, T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.016 · Cited by 55
New emerging roles of microRNAs in breast cancer
Mandujano-Tinoco, E. A., García-Venzor, A., Meléndez-Zajgla, J., & Maldonado, V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4850-7 · Cited by 55
Chai, C., Wu, H., Wang, B., Eisenstat, D. D., & Leng, R. P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy092 · Cited by 55
A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer
Liu, J., Li, X., Wang, M., Xiao, G., Yang, G., Wang, H., Li, Y., Sun, X., Qin, S., Du, N., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4492 · Cited by 55
Xie, D., Song, H., Wu, T., Li, D., Hua, K., Xu, H., Zhao, B., Wu, C., Hu, J., Ji, C., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6741 · Cited by 55
Li, G., Yao, L., Zhang, J., Li, X., Dang, S., Zeng, K., Zhou, Y., & Gao, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-4623-4 · Cited by 52
Shi, P., Chen, C., Li, X., Wei, Z., Liu, Z., & Liu, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10044 · Cited by 51
MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer
Zhou, L., Dong, J. L., Huang, G., Sun, Z., & Wu, J. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20175891 · Cited by 50
MicroRNA-16 Modulates HuR Regulation of Cyclin E1 in Breast Cancer Cells
Guo, X., Connick, M. C., Vanderhoof, J., Ishak, M.-A., & Hartley, R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047112 · Cited by 49
Yang, L., Cai, Y., Zhang, D., Sun, J., Xu, C., Zhao, W., Jiang, W., & Pan, C. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.e60 · Cited by 48
Dinami, R., Buemi, V., Sestito, R., Zappone, A., Ciani, Y., Mano, M., Petti, E., Sacconi, A., Blandino, G., Giacca, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21180 · Cited by 42
Ludlow, A. T., Slusher, A. L., & Sayed, M. (2019) · Cancers · doi:10.3390/cancers11050666 · Cited by 41
MicroRNA-200b Impacts Breast Cancer Cell Migration and Invasion by Regulating Ezrin-Radixin-Moesin
Hong, H., Yu, H., Yuan, J., Guo, C., Cao, H., Li, W., & Xiao, C. (2016) · Medical Science Monitor · doi:10.12659/msm.896551 · Cited by 40
Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer
Shao, B., Wang, X., Zhang, L., Li, D., Liu, X., Song, G., Cao, H., Zhu, J., & Li, H. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819828709 · Cited by 39
HIF-1α Promotes Breast Cancer Cell MCF-7 Proliferation and Invasion Through Regulating miR-210
Zhang, Y., Yan, J., Wang, L., Dai, H., Li, N., Hu, W., & Cai, H. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2270 · Cited by 37
Tumor suppressor function of miR‑483‑3p on breast cancer via targeting of the cyclin E1 gene
Huang, X., & Lyu, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6504 · Cited by 36
WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206
Ren, Y., Wang, H., Zhang, Y., & Liu, Y. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3302-0 · Cited by 33
The diverse roles of RNA helicases in RNAi
Ambrus, A., & Frolov, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9887 · Cited by 32
CRISPR deletion of MIEN1 in breast cancer cells
Treuren, T. V., & Vishwanatha, J. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204976 · Cited by 30
Ohzawa, H., Miki, A., Teratani, T., Shiba, S., Sakuma, Y., Nishimura, W., Noda, Y., Fukushima, N., Fujii, H., Hozumi, Y., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.5628 · Cited by 28
Nonredundant, Highly Connected MicroRNAs Control Functionality in Breast Cancer Networks
de Anda‐Jáuregui, G., Enríquez, J. E., Garcia, D. D., & Lemus, E. H. (2018) · International Journal of Genomics · doi:10.1155/2018/9585383 · Cited by 25
Genome‐Wide Mapping and Analysis of Grapevine MicroRNAs and Their Potential Target Genes
Jiu, S., Zhu, X., Wang, J., Zhang, C., Mu, Q., Wang, C., & Fang, J. (2015) · The Plant Genome · doi:10.3835/plantgenome2014.12.0091 · Cited by 24
Huszno, J., Budryk, M., Kołosza, Z., & Nowara, E. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.50014 · Cited by 22
Murakami, K., & Miyagishi, M. (2014) · Biomedical Reports · doi:10.3892/br.2014.260 · Cited by 22
An, X., Quan, H., Lv, J., Meng, L., Wang, C., Yu, Z., & Han, J. (2018) · Future Oncology · doi:10.2217/fon-2018-0334 · Cited by 19
miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells
Harquail, J., LeBlanc, N., Ouellette, R. J., & Robichaud, G. A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy191 · Cited by 12
Tiwari, M. (2011) · Indian journal of human genetics · doi:10.4103/0971-6866.92081 · Cited by 3
Cited by
Mustafa, M., Ahmad, R., Tantry, I. Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Moinuddin, Hassan, M. I., Habib, S., et al. (2024) · Cells · doi:10.3390/cells13221838 · Cited by 595
Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)
Smolarz, B., Nowak, A. Z., & Romanowicz, H. (2022) · Cancers · doi:10.3390/cancers14102569 · Cited by 587
miRNAs in Cancer (Review of Literature)
Smolarz, B., Durczyński, A., Romanowicz, H., Szyłło, K., & Hogendorf, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052805 · Cited by 296
Metadata
- Authors
- Loh, H.-Y., Norman, B. P., Lai, K.-S., Rahman, N. M. A. N. A., Alitheen, N. B. M., & Osman, M. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-10-06
- Volume
- 20
- Issue
- 19
- Pages
- 4940
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2977306097
- Cited by
- 326
- References
- 146
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.